Riskpilot← Back to searchSign inGet full accessCopenhagen Bioengineering ApS
APSActiveCVR 37640549Tingvej 1Leasing of intellectual property and similar products, except copyrighted works · NACE 7740Est. 20161 employees
Revenue 2024
DKK 137K
-27% vs 2023
EBITDA margin
51.2%
-50% vs 2023
Equity ratio
97.5%
Financial strength
Net profit 2024
DKK 27K
-64% vs 2023
| Revenue | DKK 137K | -27% |
| EBITDA | DKK 70K | -50% |
| Net profit | DKK 27K | -64% |
| Total assets | DKK 1M | +2% |
| Equity | DKK 1M | +3% |
| Employees | 1 | — |
Legal name
Copenhagen Bioengineering ApS
CVR number
37640549
Legal form
Anpartsselskab
NACE code
7740 · Leasing of intellectual property and similar products, except copyrighted works
Founded
26. april 2016
Share capital
DKK 50.050
Employees
1 (FTE)
VAT registered
Yes
Audit selected
Yes
Last report
2024-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af den samlede bestyrelse eller af direktionen
Company purpose
Selskabets formål er at drive virksomhed med udvikling af immaterielle rettigheder og licensering af samme samt dermed beslægtet virksomhed
Address
Tingvej 1
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | -53 | 53 | 262 | 531 | 693 | 243 | -484 | 187 | 137 |
| Staff expenses | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -47 | -67 |
| EBITDA | -53 | 53 | 262 | 531 | 693 | 243 | -484 | 140 | 70 |
| Depreciation & amort. | -0 | -0 | -0 | -2 | -20 | -35 | -46 | -46 | -44 |
| EBIT | -53 | 53 | 262 | 529 | 673 | 208 | -530 | 94 | 26 |
| Net financials | 0 | -1 | -2 | -7 | -12 | -5 | -0 | 4 | 9 |
| Profit before tax | -53 | 52 | 260 | 522 | 661 | 203 | -530 | 98 | 35 |
| Tax | -0 | 1 | 57 | 116 | 147 | 45 | -116 | 22 | 7 |
| Net profit | -53 | 51 | 202 | 406 | 514 | 158 | -414 | 76 | 27 |
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|
| Total assets | 2 | 58 | 331 | 800 | 1.343 | 1.426 | 1.018 | 1.021 | 1.045 |
| Equity | -3 | 48 | 250 | 657 | 1.171 | 1.329 | 915 | 991 | 1.019 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 5 | 10 | 81 | 138 | 167 | 84 | 103 | 30 | 26 |
| Total debt | 5 | 10 | 81 | 138 | 167 | 84 | 103 | 30 | 26 |
EBITDA margin
51.2%
This company
15.8%
Market median
+224% vs market
20162024
Equity ratio
97.5%
This company
38.2%
Market median
+155% vs market
20162024
Return on equity
2.7%
This company
18.4%
Market median
-85% vs market
20162024
Net profit margin
19.9%
This company
8.1%
Market median
+146% vs market
20162024
Asset turnover
0.13×
This company
1.12×
Market median
-88% vs market
20162024
Debt / equity
0.03×
This company
0.62×
Market median
+95% vs market
20162024
- Annual report 2024Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via CVR / Virk · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via CVR / Virk · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via CVR / Virk · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via CVR / Virk · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via CVR / Virk · Period 2016-04-26 – 2016-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
HA Management | Management | 2016 | — | — |
MF Management | Management | 2022 | — | — |
PF Chief Executive Officer | Chief Executive Officer | 2022 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2016 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
P.F. Kaaber Holding ApS | Company | 25.0% | 25.0% | 2022 |
Strukturforsyningen ApS | Company | 25.0% | 25.0% | 2022 |
Holtug Holding ApS | Company | 25.0% | 25.0% | 2022 |
M.F. Kaaber Holding ApS | Company | 20.0% | 20.0% | 2019 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Strukturforsyningen ApS
Copenhagen Bioengineering ApS Board members of Copenhagen Bioengineering ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Helge Anker Andreasen | Management | 0 companies |
| Marco Falkenløve Kaaber | Management | 0 companies |
| Phillip Falkenløve Kaaber | Chief Executive Officer | 0 companies |
| Niels Juul Jensen | Board of Directors | 0 companies |